Inquiry Basket
Loading ......
CD34 is a cell surface transmembrane sialomucin that has served as a practical marker of hematopoietic stem and progenitor cells for several decades. It is expressed on the most primitive blood forming cells in the bone marrow and on the cord blood and mobilized peripheral blood compartments used for stem cell transplantation. Beyond hematopoiesis, CD34 is also displayed by vascular endothelial cells and a range of perivascular stromal elements, which makes it a broadly useful marker for vascular and progenitor biology. The molecule belongs to a small family of related sialomucins that share a conserved architecture and a heavily glycosylated extracellular mucin domain. Although CD34 is among the most widely used markers in clinical and research immunophenotyping, its precise molecular functions remain actively investigated. This article reviews the structural features of CD34, its membership in the podocalyxin family alongside podocalyxin and endoglycan, also called MEP21, its role as a marker of hematopoietic stem and progenitor cells, its activity as a ligand for L-selectin in leukocyte trafficking, and its expression in endothelial and perivascular contexts during vasculogenesis. The goal is to give researchers a clear, structure focused picture of this important sialomucin.
CD34 is a single pass type I transmembrane phosphoglycoprotein whose extracellular region is organized as a classical sialomucin. The N terminal ectodomain contains a mucin domain built from serine, threonine, and proline rich repeats that are extensively O glycosylated and sialylated. This dense coat of carbohydrate creates a rigid, highly hydrated, and strongly negatively charged exterior that gives the mature protein an apparent molecular mass in the range of 90 to 170 kilodaltons. Beneath the mucin region sits a cysteine rich globular domain, followed by a juxtamembrane segment and then the transmembrane helix, with a short cytoplasmic tail on the inner face of the membrane. The cytoplasmic tail carries conserved phosphorylation sites and binding motifs that can engage intracellular partners, which hints that CD34 does more than simply decorate the cell surface. The overall architecture, a mucin domain plus a globular cysteine region plus a transmembrane span plus a signaling competent tail, is the signature layout of the CD34 family of sialomucins. Post translational modification is central to CD34 function because only certain glycoforms present the appropriate sialylated and sulfated structures needed for recognition by lectin like receptors. The sialomucin character of CD34 therefore explains both its anti adhesive properties on the cell surface and its capacity to act as a carbohydrate dependent ligand in cell adhesion events.
Figure 1. Schematic representation of the two CD34 forms. (Source: Rodrigues CR, et al. 2023)
CD34 is the prototypic member of a small family of transmembrane sialomucins that also includes podocalyxin and endoglycan. Endoglycan is also known as MEP21 in earlier literature, where it was identified as a related mucin expressed on early hematopoietic precursors. These three proteins share the same basic domain organization, an extracellular mucin domain, a cysteine containing globular region, a single pass transmembrane segment, and a cytoplasmic tail with conserved sequence motifs. Podocalyxin is best known for its abundant expression on kidney podocytes, where it maintains the open filtration slits between foot processes through its strong negative charge and anti adhesive effect. Endoglycan, by contrast, is found on a subset of hematopoietic cells and endothelial structures and participates in adhesion and migration related processes. The cytoplasmic tails of all three family members are similar enough to bind related PDZ domain containing adaptor proteins, which links the extracellular mucin to the actin cytoskeleton and to intracellular trafficking machinery. This shared architecture suggests that the family arose from a common ancestor and diversified to serve tissue specific roles while retaining a core function in modulating cell adhesion and cell surface charge. Studying podocalyxin and endoglycan alongside CD34 helps clarify which features are general to the family and which are unique to CD34 in hematopoietic and vascular contexts.
In adult human bone marrow, CD34 marks the bulk of hematopoietic stem and progenitor cells, spanning long term repopulating stem cells through increasingly committed oligopotent and unipotent progenitors. Surface expression is typically high on primitive cells and is downregulated as cells mature into terminal effectors such as lymphocytes, granulocytes, and erythrocytes, which is why CD34 positive selection remains a workhorse of stem cell transplantation and graft engineering. Within the hematopoietic hierarchy, CD34 is used together with other markers to resolve cell states. CD117, also known as c-KIT, marks a more primitive stem and progenitor compartment and is commonly combined with CD34 to isolate long term repopulating cells. CD45 serves as the pan leukocyte marker that defines the hematopoietic lineage and is used to exclude non hematopoietic events during flow analysis. CD31, also called PECAM-1, helps distinguish endothelial progenitors and certain progenitor subsets from bulk CD34 positive cells. The CD34 positive fraction is nonetheless heterogeneous, and some repopulating activity also resides in CD34 negative cells, which has prompted refinement of isolation strategies using additional markers. CD34 expression itself appears to influence progenitor behavior rather than merely label it, because experimental reduction of CD34 in model systems alters progenitor numbers and proliferative capacity. This positions CD34 as both a practical isolation marker and a molecule with genuine, if still debated, roles in maintaining the progenitor phenotype during blood formation.
Figure 2. Hierarchy of hematopoiesis. (Source: Chotinantakul K, et al. 2012)
One of the best characterized functions of CD34 is its role as a ligand for L-selectin, a lectin like adhesion receptor expressed on leukocytes. On high endothelial venules of lymph nodes and other specialized vessels, CD34 is displayed in a glycoform that carries sialylated and sulfated carbohydrates recognized by L-selectin. This interaction supports the tethering and rolling of lymphocytes along the vessel wall, an early step in lymphocyte homing to lymphoid tissues. The same family members, podocalyxin and endoglycan, can also present L-selectin reactive glycoforms, but only a limited set of vessels generates the correctly modified structures, which explains why CD34 is widely expressed on endothelium yet only certain vessels act as L-selectin ligands. VCAM-1 and other endothelial adhesion molecules cooperate with selectin mediated tethering to enable firm adhesion and transmigration, so CD34 contributes to a multistep adhesion cascade rather than acting alone. In hematopoietic stem and progenitor cells, CD34 dependent interactions with L-selectin on endothelium have also been proposed to influence homing of transplanted cells to the bone marrow niche. The context dependent nature of this function is important, because CD34 can behave as a pro adhesive ligand in one setting and as an anti adhesive, migration promoting molecule in another, depending on which glycosylation state and which partner molecules are present.
Outside the hematopoietic system, CD34 is a reliable marker of vascular endothelial cells and of the perivascular stromal cells that support vessel stability. Capillaries and small vessels in most tissues express CD34 on their endothelial lining, which makes it valuable for identifying endothelial cells in immunohistochemistry and for isolating endothelial progenitors from blood or tissue. During vasculogenesis and angiogenesis, CD34 positive endothelial progenitor cells contribute to the formation and repair of vessels, and the molecule is commonly used together with endothelial markers such as CD31 and with receptors such as VEGFR2, also known as FLK1, to define the endothelial lineage. The perivascular niche, populated by CD34 positive stromal and progenitor cells, provides signals that help maintain hematopoietic stem cells within the bone marrow, linking endothelial and hematopoietic biology through a shared marker. CD34 on endothelium also participates in the charged, anti adhesive surface that limits inappropriate cell attachment, analogous to the role of podocalyxin in the kidney. Because CD34 is expressed on both the blood forming progenitors and the vessels that house them, it is a useful anchor for studying how stem cell niches are organized. The combination of endothelial, perivascular, and progenitor expression explains why CD34 appears across so many tissue contexts and why it remains a reference marker for vascular and stromal compartments in developmental and regenerative studies.
Detection and study of CD34 rely on a set of generic research grade reagents rather than any single proprietary tool. Defined specificity monoclonal antibodies that recognize extracellular epitopes of CD34 are the standard reagents for flow cytometry, immunohistochemistry, and immunofluorescence, where they resolve CD34 positive from CD34 negative populations. Recombinant forms of the CD34 ectodomain, produced without animal derived components, are used to probe ligand interactions such as binding to L-selectin in solid phase or cell based assays. Lectin reagents and carbohydrate specific probes help distinguish the sialylated and sulfated glycoforms that determine ligand activity, while reference cell lines and primary CD34 positive cells serve as positive controls for assay validation. Mass spectrometry based glycoproteomics is applied to map the site specific glycosylation that underlies CD34 function, and validated secondary antibodies conjugated to fluorophores or enzymes support multiplexed phenotyping alongside other markers. Researchers should select reagents according to the intended application and validate specificity on relevant tissues, because the carbohydrate dependent functions of CD34 mean that detection of protein alone may not capture its functional state. Careful reagent validation keeps CD34 studies comparable across laboratories.
References
| Target | Cat. No. | Product Name | Application | Detection Sample | |
| CD34 | DEIA-BJ2404 | Mouse Cluster of differentiation 34 ELISA Kit | Quantitative | Serum, plasma, cell culture supernatants, body fluid and tissue homogenate | Inquiry |
| Target | Cat. No. | Product Name | Expression System | Tag/Conjugate | Application | |
| CD34 | DAGC-55231 | Recombinant Human CD34 (a.a. 32-290) Protein [His] | Baculovirus | His | SDS-PAGE | Inquiry |
Loading ......
